Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic and Predictive Markers of Benefit from Adjuvant Chemotherapy in Early-Stage Non-small Cell Lung Cancer

Published:2009-07 Issue:7 Volume:4 Page:891-910
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Custodio Ana Belén,González-Larriba José Luis,Bobokova Jana,Calles Antonio,Álvarez Rafael,Cuadrado Eugenio,Manzano Aranzazu,Díaz-Rubio Eduardo

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference144 articles.

1. Cancer statistics, 2006;Jernal;CA Cancer J Clin,2006

2. Surgical treatment of non small cell lung cancer;Ponn,2005

3. Surgery for early-stage non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials;Wright;Thorax,2006

4. Adjuvant chemotherapy of lung cancer: methodologic issues and therapeutic advances;Strauss;Hematol Oncol Clin North Am,2005

5. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer;N Engl J Med,2004

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparanase accelerates the angiogenesis and inhibits the ferroptosis of p53-mutant non-small cell cancers in VEGF-dependent manner;Cytotechnology;2024-05-16

2. The role of leptin in regulation of the soluble amyloid precursor protein α (sAPPα) levels in lung cancer cell media;Scientific Reports;2024-02-28

3. Lung adenocarcinomas with isolated TP53 mutation: A comprehensive clinical, cytopathologic and molecular characterization;Cancer Medicine;2024-01

4. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC);Pathology - Research and Practice;2023-12

5. Heterogeneity in precision oncology;Cambridge Prisms: Precision Medicine;2023-10-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3